Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Thymoma × Proton Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Meningioma 3 Brain Neoplasms 3 Sarcoma 2 Radiation Injuries 2 Prostatic Neoplasms 2 Pituitary Neoplasms 2 Nerve Sheath Neoplasms 2 Neoplasms 2 Esophageal Neoplasms 2 Wilms Tumor 1 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Resectable Lung Non-Small Cell Carcinoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neurofibrosarcoma 1 Neurilemmoma 1 Neoplasms, Adipose Tissue 1 Nasopharyngeal Carcinoma 1 Myoepithelioma 1 Malignant Brain Glioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1

Interventions

pembrolizumab 3 Drug Therapy 2 zimberelimab 1 lenvatinib 1 fludarabine 1 Sunitinib 1 Radiotherapy, Adjuvant 1 Radiotherapy 1 Proton Therapy 1 Paclitaxel 1 Immunotherapy 1 Heavy Ion Radiotherapy 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡